株探米国株
日本語 英語
エドガーで原本を確認する
false 0001620179 0001620179 2024-04-04 2024-04-04 0001620179 us-gaap:CommonStockMember 2024-04-04 2024-04-04 0001620179 xela:SixPercentSeriesBCumulativeConvertiblePerpetualPreferredStockParValueDollar0.0001PerShareMember 2024-04-04 2024-04-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 4, 2024

 

EXELA TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-36788   47-1347291
(State or other jurisdiction
of incorporation or organization)
  (Commission File Number)  

(I.R.S. Employer
Identification Number)

 

2701 East Grauwyler Road

Irving, Texas

  75061
(Address of principal executive offices)   (Zip Code)

 

Company’s telephone number, including area code: (844) 935-2832

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading
Symbol
Name of Each Exchange
on
Which Registered
Common stock, par value $0.0001 per share XELA The Nasdaq Stock Market LLC
6.00% Series B Cumulative Convertible Perpetual Preferred Stock, par value $0.0001 per share XELAP The Nasdaq Stock Market LLC

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

¨ Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 


 

Item 2.02 Results of Operations and Financial Condition.

 

Attached hereto as Exhibit 99.1 is a copy of a press release of Exela Technologies, Inc., dated April 4, 2024, announcing certain operating results for the fiscal quarter and year ended December 31, 2023. The information in the press release is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.

 

In accordance with General Instruction B.2 on Form 8-K, the information set forth under this Item 2.02 of this Current Report on Form 8-K, including the press release attached as an exhibit hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
99.1   Press Release, dated April 4, 2024
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 4, 2024

 

  EXELA TECHNOLOGIES, INC.
     
  By: /s/ Zach Maul
    Name: Zach Maul
    Title: Secretary

 

 

 

EX-99.1 2 tm2411057d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Exela Technologies Holdings, Inc. Reports Full Year 2023 Results

 

Full Year Highlights

 

· 2023 revenue of $1,064.1 million, down 1.2% year-over-year

 

· Gross margin of 21.7% in 2023 vs 18.5% in 2022

 

· Operating profit of $8.1 million, up $236.8 million due to increased gross margin, lower SG&A and no impairments in 2023 versus 2022

 

· Net loss of $124.4 million ($125.1 attributable to Exela Technologies Inc), an improvement of $291.4 million year-over-year

 

· Certain of the Company’s subsidiaries issued approximately $764.8 million of aggregate principal amount of new notes in exchange for $956.0 million of aggregate principal amount of existing 2026 notes in 2023

 

IRVING, TX April 4, 2024 (GLOBE NEWSWIRE) – Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP), a global business process automation (“BPA”) leader, announced today its financial results for the full year ended December 31, 2023.

 

“2023 was a challenging year with focus on stabilizing revenues and recovering from the effects of our network outage in 2022. We made significant improvement to our balance sheet, eliminating current liabilities, and reducing our overall debt and interest expense under a difficult macro environment and uncertain outlook. We maintained our focus on cost management and leveraging automationand have 2023 initiatives in process continuing into 2024 to achieve our margin improvement goals.

 

Late in the year, we made investments to position the Company for future growth by entering into cyber security, data modernization, cloud and Infrastructure-as-a-Service, in addition to previously announced investments in FAO and data science. We completed the public listing on Nasdaq of XBP Europe, our European business. We also made significant investments in people. We improved gross margins and operating income, however we did not accomplish all of our goals in 2023 and have room to grow,” said Par Chadha, Executive Chairman of Exela Technologies.

 

Full Year Highlights

 

· Revenue: Revenue for 2023 was $1,064.1 million, a decline of 1.2% compared to $1,077.2 million in 2022

 

· Revenue for the Information and Transaction Processing Solutions segment was $732.3 million, a decline of 4.3% year-over-year

 

· Healthcare Solutions generated $251.4 million, a 5.0% increase year-over-year

 

· Legal and Loss Prevention Services generated $80.4 million in revenue, a 10.6% increase year-over-year

 

· Operating profit: Operating profit in 2023 was $8.0 million, up $236.8 million compared with an operating loss of $228.8 million in 2022. Higher gross margin from technology advancements, lower SG&A with reductions in professional services and facility expenses, and a lack of goodwill impairment contributed to the profit improvement on a year-over-year basis.

 

· Net Loss: Net loss for 2023 was $124.4 million ($125.1 attributable to Exela Technologies Inc), an improvement of $291.4 million compared with a net loss of $415.6 million in 2022. The year over year decrease was materially driven by improvements in operating profit, lower interest expense and a gain on debt modification and extinguishment costs relative 2022.

 

· Adjusted EBITDA(1): Adjusted EBITDA for 2023 was $60.0 million compared to $56.8 million in 2022. Adjusted EBITDA margin for 2023 was 5.6%, an increase of 30 basis points from 2022.

 

· Capital Expenditures: Capital expenditures for 2023 were 1.1% of revenue compared to 2% of revenue in 2022 as we continue to migrate from capital intensive infrastructure to cloud computing, by making investments in our platforms and operations.

 

Below is the note referenced above:

 

(1) Adjusted EBITDA is a non-GAAP measure. A reconciliation of Adjusted EBITDA is attached to this release.

 

 


 

About Exela

 

Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over 60% of the Fortune® 100. Utilizing foundational technologies spanning information management, workflow automation, and integrated communications, Exela’s software and services include multi-industry, departmental solution suites addressing finance and accounting, human capital management, and legal management, as well as industry-specific solutions for banking, healthcare, insurance, and the public sector. Through cloud-enabled platforms, built on a configurable stack of automation modules, and approximately 14,100 employees operating in 20 countries, Exela rapidly deploys integrated technology and operations as an end-to-end digital journey partner.

 

To automatically receive Exela financial news by e-mail, please visit the Exela Investor Relations website, http://investors.exelatech.com/, and subscribe to E-mail Alerts.

 

Forward-Looking Statements

 

Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation the network outage described in this press release and those discussed under the heading “Risk Factors” in our Annual Report and in subsequent filings with the U.S. Securities and Exchange Commission (“SEC”). In addition, forward-looking statements provide Exela’s expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela’s assessments to change. These forward-looking statements should not be relied upon as representing Exela’s assessments as of any date subsequent to the date of this press release.

 

 


 

For more Exela news, commentary, and industry perspectives, visit:

 

Website: https://investors.exelatech.com/

 

X: @ExelaTech

 

LinkedIn: /exela-technologies

 

Facebook: @exelatechnologies

 

Instagram: @exelatechnologies

 

The information posted on the Company's website and/or via its social media accounts may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its social media accounts in addition to the Company's press releases, SEC filings and public conference calls and webcasts.

 

Investor and/or Media Contacts:

 

Vincent Kondaveeti

 

E: vincent.kondaveeti@exelatech.com

 

 


 

Exela Technologies, Inc. and Subsidiaries

 

Consolidated Balance Sheets

 

As of December 31, 2023 and 2022

(in thousands of United States dollars except share and per share amounts)

 

    December 31,  
    2023     2022  
Assets                
Current assets                
Cash and cash equivalents   $ 23,341     $ 15,073  
Restricted cash     43,812       29,994  
Accounts receivable, net of allowance for credit losses of $6,628 and $6,402, respectively     76,893       101,616  
Related party receivables and prepaid expenses     296       759  
Inventories, net     11,502       16,848  
Prepaid expenses and other current assets     25,364       26,206  
Total current assets     181,208       190,496  
Property, plant and equipment, net of accumulated depreciation of $213,142 and $207,520, respectively     58,366       71,694  
Operating lease right-of-use assets, net     33,874       40,734  
Goodwill     170,452       186,802  
Intangible assets, net     164,920       200,982  
Deferred income tax assets     3,043       1,483  
Other noncurrent assets     24,474       29,721  
Total assets   $ 636,337     $ 721,912  
                 
Liabilities and Stockholders' Deficit                
Liabilities                
Current liabilities                
Current portion of long-term debt   $ 30,029     $ 154,802  
Accounts payable     61,109       79,249  
Related party payables     1,938       2,473  
Income tax payable     2,080       2,045  
Accrued liabilities     63,699       61,340  
Accrued compensation and benefits     65,012       54,143  
Accrued interest     52,389       60,901  
Customer deposits     23,838       16,955  
Deferred revenue     12,099       16,405  
Obligation for claim payment     66,988       44,380  
Current portion of finance lease liabilities     4,856       5,485  
Current portion of operating lease liabilities     10,845       11,867  
Total current liabilities     394,882       510,045  
Long-term debt, net of current maturities     1,030,580       942,035  
Finance lease liabilities, net of current portion     5,953       9,448  
Pension liabilities, net     13,192       16,917  
Deferred income tax liabilities     11,692       11,180  
Long-term income tax liabilities     6,359       2,742  
Operating lease liabilities, net of current portion     26,703       31,030  
Other long-term liabilities     5,811       6,104  
Total liabilities     1,495,172       1,529,501  
Commitments and Contingencies (Note 14)                
Stockholders' deficit                
Common Stock, par value of $0.0001 per share; 1,600,000,000 shares authorized; 6,365,353 shares issued and outstanding at December 31, 2023 and 1,393,889 shares issued and 1,393,276 shares outstanding at December 31, 2022     261       162  
Preferred stock, $0.0001 par value per share, 20,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively                
Series A Preferred Stock, 2,778,1 11 shares issued and outstanding at December 31, 2023 and December 31, 2022     1       1  
Series B Preferred Stock, 3,029,900 shares issued and outstanding at December 31, 2023 and O shares issued and outstanding at December 3 I, 2022     ¾       ¾  
Additional paid in capital     1,179,098       1,102,619  
Less: Common Stock held in treasury, at cost; 0 shares at December 31, 2023 and 612 shares at December 31, 2022     ¾       (10,949 )
Equity-based compensation     57,073       56,958  
Accumulated deficit     (2,084,114 )     (1,948,009 )
Accumulated other comprehensive loss:                
Foreign currency translation adjustment     (7,648 )     (4,788 )
Unrealized pension actuarial losses, net of tax     (174 )     (3,583 )
Total accumulated other comprehensive loss     (7,822 )     (8,371 )
Total stockholders' deficit attributable to Exela Technologies, Inc.     (855,503 )     (807,589 )
Noncontrolling interest in XBP Europe     (3,332 )     ¾   
Total stockholders' deficit     (858,835 )     (807,589 )
Total liabilities and stockholders' deficit   $ 636,337     $ 721,91  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 


 

Exela Technologies, Inc. and Subsidiaries

 

Consolidated Statements of Operations

 

For the years ended December 31, 2023 and 2022

(in thousands of United States dollars except share and per share amounts)

 

    Years ended December 31,  
    2023     2022  
Revenue   $ 1,064,124     $ 1,077,157  
Cost of revenue (exclusive of depreciation and amortization)     833,422       877,474  
Selling, general and administrative expenses ( exclusive of depreciation and amortization)     150,672       176,524  
Depreciation and amortization     60,535       71,831  
Impairment of goodwill and other intangible assets     —        171,182  
Related party expense     11,444       8,923  
Operating profit (loss)     8,051       (228,777 )
Other expense (income), net:                
Interest expense, net     139,656       164,870  
Debt modification and extinguishment costs (gain), net     (16,129 )     4,522  
Sundry expense (income), net     973       (957 )
Other expense (income), net     (884 )     14,170  
Loss before income taxes     (115,565 )     (411,382 )
Income tax expense     (8,868 )     (4,199 )
Net loss     (124,433 )     (415,581 )
Net profit (loss) attributable to noncontrolling interest in XBP Europe, net of taxes     723       —   
Net loss attributable to Exela Technologies, Inc.   $ (125,156 )   $ (415,581 )
Cumulative dividends for Series A Preferred Stock     (3,961 )     (3,588 )
Cumulative dividends for Series B Preferred Stock     (4,718 )     (3,665 )
Net loss attributable to common stockholders   $ (133,835 )   $ (422,834 )
Loss per share:                
Basic and diluted   $ (22.37 )   $ (1,372.98 )

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 


 

Exela Technologies, Inc. and Subsidiaries

 

Consolidated Statements of Cash Flows

 

For the years ended December 31, 2023 and 2022

(in thousands of United States dollars unless otherwise stated)

 

    Years ended December 31,  
    2023     2022  
Cash flows from operating activities                
Net loss   $ (124,433 )   $ (415,581 )
Adjustments to reconcile net loss                
Depreciation and amortization     60,535       71,831  
Original issue discount,. debt premium and debt issuance cost amortization     5,411       15,261  
Interest paid on BR Exar AR Facility     (10,754 )     ¾   
Debt modification and extinguishment gain, net     (17,534 )     (1,803 )
Impairment of goodwill and other intangible assets     ¾        171,182  
Impairment of operating lease right-of-use assets     1,942          
Credit loss expense     4,486       1,573  
Deferred income tax. provision     (1,048 )     147  
Share-based compensation expense     115       970  
Unrealized foreign currency gain     (70 )     (1,288 )
(Gain) loss on sale of assets     (7,044 )     707  
Fair value adjustment for private warrants liability of XBP Europe     597       ¾   
Change in operating assets and liabilities                
Accounts receivable     22,729       77,650  
Prepaid expenses and other current assets     5,523       (7,813
Accounts payable and accrued liabilities     63,711       (520 )
Related party payables     (71 )     945  
Additions to outsource contract costs     (539 )     (423 )
Net cash provided by (used in) operating activities     3,556       (87,162 )
Cash flows from investing activities                
Purchase of property, plant and equipment     (8,075 )     (18,299 )
Additions to patents     ¾        (15 )
Additions to internally developed software     (3,818 )     (3,650 )
Proceeds from sale of assets     29,811       194  
Net cash provided by (used in) investing activities     17,918       (21,770 )
Cash flows from financing activities                
Proceeds from issuance of Common Stock from private placement     ¾        55  
Proceeds from issuance of Common Stock from at the market offerings     69,260       276,337  
Cash received in exchange for the issuance of noncontrolling interest shares in XBP Europe     5,205       ¾   
Cash paid for equity issuance costs from at the market offerings     (2,232 )     (9,482 )
Dividend paid on Series B Preferred Stock     ¾        (2,532 )
Payment for fractional mates on reverse stock split     (31 )     ¾   
Repurchases of Common Stock for retirement     ¾        (487 )
Borrowings under factoring arrangement and Securitization Facility     88,396       123,353  
Principal repayment on borrowings under factoring arrangement and Securitization Facility     (92,536 )     (216,812
Cash paid for withholding taxes on vested RSUs     ¾        (135 )
Lease terminations     ¾        3  
Cash paid for debt issuance costs     (8,496 )     (7,125
Principal payments on finance tease obligations     (4,570 )     (5,523 )
Borrowings from senior secured revolving facility and BRCC revolver     9,600       20,000  
Repayments on senior secured revolving facility     ¾        (49,477 )
Proceeds from issuance of July 2026 Notes     ¾        70,269  
Borrowings from other loans     8,709       10,095  
Cash paid for debt repurchases     (11,858 )     (4,712
Proceeds from Senior secured term loan     40,000       ¾   
Proceeds from Second Lien Note     31,500       ¾   
Borrowing under BR Exar AR Facility     42,539       ¾   
Repayments under BR Exar AR Facility     (42,546 )     ¾   
Repayment of BRCC term loan     (48,529 )     (66,471 )
Principal repayments on senior secured term loans and other loans     (83,787 )     (30,717 )
Net cash provided by financing activities     624       106,639  
Effect of exchange rates on cash, restricted cash and cash equivalents     (12 )     (700 )
Net increase (decrease) in cash, restricted cash and cash equivalents     21,086       (2,993 )
Cash, restricted cash, and cash equivalents                
Beginning of period     45,067       48,060  
End of period   $ 67,153     $ 45,067  
Supplemental cash flow data:                
Income tax payments, net of refunds received   $ 5,494     $ 5,790  
Interest paid     111,835       98,602  
Noncash investing and financing activities:                
Assets acquired through right-of-use arrangements   $ 405     $ 4,790  
Issuance of April 2026 Notes in exchange of July 2026 Notes     764,800       ¾  
Issuance of April 2026 Notes in exchange of 2023 term loan     2,963       ¾  
Accrued PIK interest paid through issuance of PIK Notes     44,146       ¾  
Common Stock exchanged for Series B Preferred Stock      ¾       6  
Accrued liability for true-up obligation settled through the issuance of July 2026 Notes     ¾       10,351  
Accrued capital expenditures     2,261       1,851  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 


 

Exela Technologies, Inc. and Subsidiaries

Schedule 1: Reconciliation of Adjusted EBITDA and constant currency revenues

 

    Year Ended December 31,  
    2023     2022  
Net Loss   $ (124,433 )   $ (415,581 )
Taxes     8,868       4,199  
Interest expense     139,656       164,870  
Depreciation and amortization     60,535       71,831  
EBITDA     84,626       (174,681 )
Transaction and integration costs (1)     6,172       18,586  
Non-cash equity compensation (2)     115       985  
Other charges including non-cash (3)     (12,991 )     35,932  
Loss/(gain) on sale of assets (4)     1,105       1,357  
Loss/(gain) on business disposals (5)     (7,223 )     —   
Debt modification and extinguishment costs (gain), net     (16,129 )     4,522  
Loss/(gain) on derivative instruments     —        (1,091 )
Exit costs related to China operations     1,850       —   
XBP Europe related de-SPAC costs     2,478       —   
Impairment of goodwill, other intangible assets     —        171,182  
Adjusted EBITDA   $ 60,003     $ 56,792  

 

(1) Represents non-recurring legal, consulting and other fees and expenses incurred in connection with acquisitions, dispositions, debt-exchanges and other extraordinary transactions and events during the applicable period.
(2) Represents the non-cash charges related to restricted stock units and options.
(3) Represents fair value adjustments to our true-up guarantee obligation under the Revolver Exchange (as defined below), network outage related costs and related insurance recoveries, legal settlement costs for class action.
(4) Represents a loss/(gain) recognized on the disposal of property, plant, and equipment and other assets.
(5) Represents a loss/(gain) recognized on the sale of high-speed scanner business in the second quarter of 2023.

 

Source: Exela Technologies, Inc.